Chargement en cours...
Ganglioside GD2 as a Therapeutic Target for Antibody-Mediated Therapy in Osteosarcoma
BACKGROUND: Survival outcomes for patients with osteosarcoma have remained stagnant over the past three decades. Targeting of ganglioside GD2, a glycosphingolipid on the cell surface of some tumors, with immunotherapy has resulted in improved outcomes for patients with neuroblastoma. The expression...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3946333/ https://ncbi.nlm.nih.gov/pubmed/24166473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28461 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|